Budiman Kharma

767 total citations
12 papers, 577 citations indexed

About

Budiman Kharma is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Budiman Kharma has authored 12 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Reproductive Medicine and 4 papers in Molecular Biology. Recurrent topics in Budiman Kharma's work include Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Budiman Kharma is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Budiman Kharma collaborates with scholars based in Japan, United States and Canada. Budiman Kharma's co-authors include Noriomi Matsumura, Masaki Mandai, Tsukasa Baba, Junzo Hamanishi, Ikuo Konishi, Ken Yamaguchi, Kaoru Abiko, Ryusuke Murakami, Yumiko Yoshioka and Kenzo Kosaka and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Budiman Kharma

12 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Budiman Kharma Japan	10	335	273	165	115	67	12	577
Maria Corallo Italy	8	300 0.9×	106 0.4×	182 1.1×	51 0.4×	83 1.2×	11	455
Véronique Cabaret France	9	392 1.2×	149 0.5×	158 1.0×	32 0.3×	72 1.1×	20	588
Rika Okamoto Japan	9	170 0.5×	229 0.8×	156 0.9×	66 0.6×	38 0.6×	14	469
Luisa Valvassori Italy	9	112 0.3×	143 0.5×	187 1.1×	55 0.5×	68 1.0×	9	424
Angela Ziebarth United States	7	254 0.8×	48 0.2×	345 2.1×	94 0.8×	125 1.9×	11	516
Mai Sugiyama Japan	13	130 0.4×	69 0.3×	210 1.3×	75 0.7×	106 1.6×	30	406
K DeSombre United States	12	203 0.6×	96 0.4×	161 1.0×	46 0.4×	40 0.6×	12	432
Masayuki Ohno Japan	11	256 0.8×	40 0.1×	264 1.6×	140 1.2×	74 1.1×	18	508
Hua Linghu China	13	105 0.3×	61 0.2×	251 1.5×	59 0.5×	91 1.4×	34	415
Antonio Agostini Norway	13	115 0.3×	77 0.3×	199 1.2×	33 0.3×	126 1.9×	26	409

Countries citing papers authored by Budiman Kharma

Since Specialization

Citations

This map shows the geographic impact of Budiman Kharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Budiman Kharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Budiman Kharma more than expected).

Fields of papers citing papers by Budiman Kharma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Budiman Kharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Budiman Kharma. The network helps show where Budiman Kharma may publish in the future.

Co-authorship network of co-authors of Budiman Kharma

This figure shows the co-authorship network connecting the top 25 collaborators of Budiman Kharma. A scholar is included among the top collaborators of Budiman Kharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Budiman Kharma. Budiman Kharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Zeng, Xiang, Tsukasa Baba, Junzo Hamanishi, et al.. (2019). Phosphorylation of STAT1 serine 727 enhances platinum resistance in uterine serous carcinoma. International Journal of Cancer. 145(6). 1635–1647. 6 indexed citations

Hamanishi, Junzo, Noriomi Matsumura, Kenji Chamoto, et al.. (2018). VISTA expressed in tumour cells regulates T cell function. British Journal of Cancer. 120(1). 115–127. 155 indexed citations

Koshiyama, Masafumi, Noriomi Matsumura, Kaoru Abiko, et al.. (2018). The effect of the type of dietary protein on the development of ovarian cancer. Oncotarget. 9(35). 23987–23999. 12 indexed citations

Mandai, Masaki, Ken Yamaguchi, Noriomi Matsumura, et al.. (2015). Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival. Oncotarget. 6(28). 26002–26017. 40 indexed citations

Jin, Peng, Yumiko Yoshioka, Masaki Mandai, et al.. (2015). The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target. Molecular Carcinogenesis. 55(4). 335–345. 30 indexed citations

Kharma, Budiman, Tsukasa Baba, Noriomi Matsumura, et al.. (2014). STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer. Cancer Research. 74(22). 6519–6530. 62 indexed citations

Baba, Tsukasa, Hyun Kang, Yuko Hosoe, et al.. (2014). Menstrual cyclic change of metastin/GPR54 in endometrium. Medical Molecular Morphology. 48(2). 76–84. 20 indexed citations

Matsumura, Noriomi, Tsukasa Baba, Ryusuke Murakami, et al.. (2014). Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta. Gynecologic Oncology. 136(1). 104–111. 20 indexed citations

Kharma, Budiman, Tsukasa Baba, Noriomi Matsumura, et al.. (2014). Abstract LB-123: Novel function of STAT1 pathway as a modulator of tumor progression in serous papillary endometrial cancer. Cancer Research. 74(19_Supplement). LB–123. 2 indexed citations

10.

Abiko, Kaoru, Masaki Mandai, Junzo Hamanishi, et al.. (2013). PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction. Clinical Cancer Research. 19(6). 1363–1374. 187 indexed citations

11.

Kharma, Budiman, Tsukasa Baba, Masaki Mandai, et al.. (2013). Utilization of genomic signatures to identify high‐efficacy candidate drugs for chemorefractory endometrial cancers. International Journal of Cancer. 133(9). 2234–2244. 10 indexed citations

12.

Kang, Hyun, Tsukasa Baba, Masaki Mandai, et al.. (2011). GPR54 Is a Target for Suppression of Metastasis in Endometrial Cancer. Molecular Cancer Therapeutics. 10(4). 580–590. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact